Caterina E. Faliti

Dec 2, 2024 | nature.com | Caterina E. Faliti |M. Williams |Natalie Haddad |Rustom Antia |John Lindner |Eliver Ghosn | +3 more

Correction to: Nature Immunology https://doi.org/10.1038/s41590-024-02010-9, published online 12 November 2024. In the version of the article initially published, in Fig. 4c, d, h and i, the colors of the keys did not match those in the bar charts. In Figs. 4h and 5g, the total cells layers were missing and in Fig. 2f and g the GMT values were not in red. These errors have now been corrected in the HTML and PDF versions of the article.

Nov 28, 2024 | cell.com | Caterina E. Faliti |Jinyong Choi |Simon Belanger |Christopher M. Tipton |Sakeenah L. Hicks |Maria Cardenas | +17 more

KeywordsantibodiesvaccineCD4 T cellsT follicular helper cellsTfh cellsplasma cellsIL-2 cytokinemTORmetabolismGet full text accessLog in, subscribe or purchase for full access. References1. Radbruch, A. ∙ Muehlinghaus, G. ∙ Luger, E.O. ... Competence and competition: the challenge of becoming a long-lived plasma cellNat. Rev. Immunol. 2006; 6:741-7502. Slifka, M.K. ∙ Antia, R. ∙ Whitmire, J.K. ... Humoral immunity due to long-lived plasma cellsImmunity. 1998; 8:363-3723.

Nov 12, 2024 | nature.com | Caterina E. Faliti |M. Williams |Natalie Haddad |Rustom Antia |John Lindner |Eliver Ghosn | +3 more

AbstractSevere acute respiratory syndrome coronavirus 2 mRNA vaccination has reduced effectiveness in certain immunocompromised individuals. However, the cellular mechanisms underlying these defects, as well as the contribution of disease-induced cellular abnormalities, remain largely unexplored.